Cordis Corporation Release: PVD Treatment Milestone Announced At Cardiovascular And Interventional Radiology Society Of Europe (CIRSE)

Medical News Today -- Cordis Corporation, a leader in peripheral vascular disease (PVD) clinical research and treatment options, announced during the annual Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Congress the placement of the one-millionth Cordis S.M.A.R.T.(R) Nitinol Self-Expandable Stent System.

MORE ON THIS TOPIC